SCHEMBL5229734

SCHEMBL5229734

CCCn1c(=O)[nH]c(=O)c2[nH]c(C3CCCCC3)nc21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 4/20 1.00
ADORA2A P29274 3/20 1.00
ADORA1 P30542 5/20 0.97
MEN1 O00255 1/20 0.69
GMNN O75496 1/20 0.69
LMNA P02545 1/20 0.69
CYP1A2 P05177 1/20 0.69
ADORA3 P0DMS8 1/20 0.69
TSHR P16473 1/20 0.69
PMP22 Q01453 1/20 0.69
KMT2A Q03164 1/20 0.69
HIF1A Q16665 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8118476 0.99 ADORA1 (1.00) ADORA2BADORA2AADORA1MEN1GMNN
SCHEMBL9645551 0.96 ADORA1 (0.95) ADORA2BADORA2AADORA1MEN1GMNN
SCHEMBL5227560 0.93 ADORA1 (0.90) ADORA2BADORA2AADORA1MEN1GMNN
SCHEMBL8126083 0.86 ADORA1 (0.77) ADORA2BADORA2AADORA1MEN1GMNN
SCHEMBL8580800 0.85 ADORA1 (0.76) ADORA2BADORA2AADORA1MEN1GMNN
SCHEMBL5231623 0.84 ADORA1 (0.73) ADORA2BADORA2AADORA1MEN1GMNN
SCHEMBL4623484 0.83 ADORA1 (1.00) ADORA2BADORA2AADORA1MEN1GMNN
SCHEMBL8578121 0.83 ADORA1 (0.72) ADORA2BADORA2AADORA1MEN1GMNN
1,3-Dipropyl-8-Cyclopentylxanthine [Dpcpx] SCHEMBL382422 0.82 ADORA1 (1.00) ADORA2BADORA2AADORA1MEN1GMNN
SCHEMBL7378595 0.81 ADORA1 (0.69) ADORA2BADORA2AADORA1MEN1GMNN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1092435-B1 REMEDIES FOR DIABETES KYOWA HAKKO KOGYO KK (JP) 2007-04-04 EP disclosed
US-6489331-B1 A CONDENSED PURINE DERIVATIVE AS AN ACTIVE INGREDIENT AS AN ENHANCER OF INSULIN SECRETION AND A MEDICAMENT FOR THE TREATMENT OF DIABETES KYOWA HAKKO KOGYO CO., LTD. (JP) 2002-12-03 US disclosed
EP-1092435-A1 REMEDIES FOR DIABETES KYOWA HAKKO KOGYO CO., LTD. (JP) 2001-04-18 EP disclosed